MMM
3M CO
Healthcare • CIK: 0000066740
Loading...
Market Cap
$83.77B
P/E (TTM)
24.6x
Rev Growth (TTM)
+1.1%
Net Margin (TTM)
13.7%
FCF Yield (TTM)
1.9%
FCF Margin (TTM)
6.4%
Filing Intelligence
4.0/10
10-K filed Feb 3, 2026 • FYNone
Executive Summary
3M's operating margins were negatively impacted by significant litigation costs and costs associated with exiting PFAS manufacturing.. Revenue was driven by strength in safety and industrial...
Key Concerns
- ●Significant ongoing litigation and regulatory proceedings worldwide carry unpredictable outcomes that could materially adversely affect the...
- ●A substantial $6.0 billion settlement for Combat Arms Earplugs litigation poses ongoing risks, including potential for additional claims,...
- ●PFAS Litigation and Regulatory Exposure (high)
Cash Flow Health
Free Cash Flow5/8 positive
TTM$1.6B
Q3 '25
$1.5B+232%
Q2 '25
$-1.2B-269%
FCF Margin
TTM6.4%
Q3 '2523.6%+229%
Sector: 0.0%Top 25%
OCF Margin10.2%
OCF/NI0.75x
CapEx Coverage2.7x
FCF Yield1.9%
FCF Growth (2Y)-26%
Cash Conversion Cycle
0 days
DSO: 0+DIO: 0−DPO: 0
Capital Allocation & Returns
Shareholder Friendly
Total Shareholder YieldTTM
TTM5.9%
Div Yield1.9%
+Buyback (TTM)4.1%
Strong capital returns to shareholders
Dividend & Payout Metrics
Dividend Yield (TTM)1.9%
FCF Payout Ratio98.2%
Free Cash Flow (TTM)$1.6B
Stock Repurchases (TTM)$3.4B
Capital Return / FCF312.2%
Est. Dividends Paid (TTM)$1.6B
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
–
Stable
+6.9%
P25MedianP75
(med: -0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
15.8%
8Q: 16.5%
Asset Turnover
0.00x
8Q: 0.60x
Leverage (1+D/E)
3.72x
D/E: 2.72x
Asset & CapEx Efficiency
CapEx/Depreciation
0.79x
Depreciation Rate Trend
⚠ Declining -2.4%
Asset-based ROIC formula
QUARTERLY TRENDS
Last 8 quarters + TTM
| Metric | TTM | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | $24.8B | $6.5B↑2.7% | $6.3B↑6.6% | $6.0B↓0.9% | $6.0B↓4.5% | $6.3B↑0.6% | $6.3B↑4.0% | $6.0B↑0.2% | $6.0B |
Operating Income | $4.9B | $1.4B↑26.9% | $1.1B↓8.5% | $1.2B | $0↓100.0% | $1.1B↓17.6% | $1.3B↑3.5% | $1.3B↑10.7% | $1.1B |
Net Income | $3.4B | $834.0M↑15.4% | $723.0M↓35.2% | $1.1B↑53.3% | $728.0M↓46.9% | $1.4B↑19.8% | $1.1B↑23.4% | $928.0M↓1.8% | $945.0M |
Operating Cash Flow | $2.5B | $1.8B↑284.1% | $-954.0M↓1107.6% | $-79.0M↓104.3% | $1.8B↑201.7% | $-1.8B↓275.0% | $1.0B↑33.1% | $767.0M↓61.4% | $2.0B |
Free Cash Flow | $1.6B | $1.5B↑232.4% | $-1.2B↓268.9% | $-315.0M↓120.6% | $1.5B↑175.1% | $-2.0B↓370.3% | $752.0M↑91.8% | $392.0M↓75.9% | $1.6B |
Total Equity | N/A |
Valuation Analysis
Fair Value
Price-to-EarningsTTM
24.6x
Volatile
8Q: 68.0x+5006%
Valuation Lenses
Earnings
24.6x
vs – sector
Cash Flow
52.7x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
–P/E per %ROIC
ROIC: –
Shareholder Returns
Dividend
1.9%
Buyback
4.1%
Total Yield
5.9%
Market Cap$83.77B
EV$83.77B
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
78/100
High Quality
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)
–
8Q:–
Return on Invested Capital (ROIC)
–
8Q:–
+6.9%
vs Sector:-0.0%
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
NOPAT Margin: 15.8%
Asset Turnover: 0.00x
Earnings Quality
Cash Conversion
0.75x
OCF / Net Income
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin40.9%
Capital Efficiency
Invested Capital Turnover–
Working Capital
Cash Conversion Cycle0 days
Growth Quality & Momentum
Low Quality
Growth Quality Score
41/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%
Growth Rates
Revenue Growth YoY
1.1%
OpInc Growth YoY
33.4%
EPS Growth YoY
-21.0%
FCF 3Y CAGR
-25.7%
Growth Quality Analysis
⚠Working Capital Drag: FCF growth lagging revenue by 26.8%
⚠Sustainability Index: 3.0/10 - Growth sustainability concerns
Margin Quality & Sustainability
Low Quality
Profitability Cascade
Gross
40.9%
Operating
19.8%
Top 25% in sector
Net
13.7%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
-7.3 pts
FCF: 6.4% | Net: 13.7%
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Leveraged
Net Debt / EBITDA
–Net Debt: $7.93B
Interest Coverage
–
Balance sheet risk & solvency analysis